Co-founders David Cranor, Natan Linder, and Maxim Lobovsky (at right) attracted backing from big-name investors like Google chairman Eric Schmidt, Lotus founder Mitch Kapor, and Media Lab director Joi Ito. And today they launched a Kickstarter campaign to take orders for the printer, the Form 1. The first batch of 25 printers were priced at $2,300, and they sold out pretty fast, helping the company blow past its original $100,000 fund-raising goal on Kickstarter in just a few hours. Buyers who weren't so quick on the draw will pay $2,500.
Below is more coverage of Formlab's launch; company background; a photo I shot in their offices earlier this month; and their Kickstarter fund-raising video.
Earlier protoypes of the Form 1 printer, on display at Formlabs' Cambridge offices.
• Wired: Formlabs Creates a Low-Cost, Light-Based 3-D Printer
• JP Morgan: Formlabs Release Could Be Negative for 3D Systems
• Formlabs' profile on AngelList
• Discussion about Formlabs on Hacker News
The Formlabs Kickstarter video:
About Scott Kirsner
Scott Kirsner was part of the team that launched Boston.com in 1995, and has been writing a column for the Globe since 2000. His work has also appeared in Wired, Fast Company, The New York Times, BusinessWeek, Newsweek, and Variety. Scott is also the author of the books "Fans, Friends & Followers" and "Inventing the Movies," was the editor of "The Convergence Guide: Life Sciences in New England," and was a contributor to "The Good City: Writers Explore 21st Century Boston." Scott also helps organize several local events on entrepreneurship, including the Nantucket Conference and Future Forward. Here's some background on how Scott decides what to cover, and how to pitch him a story idea.
Subscribe via e-mail
More from Scott
March 3: Web Innovators Group
Demos, drinks, and schmoozing at the Royal Sonesta in Cambridge.
March 7-8: MassDigi Game Challenge
Competition for aspiring game developers... plus panels and keynotes related to the business of play.
April 3-4: Mass Biotech Annual Meeting
Issues facing the region's life sciences community.